management of immature cataract (timira/ Motiyabind ) with triphaladi compound andelaneer kuzhambu anjana and Anti- Advanced Glycation End product effect of these drugs
Phase 1
Completed
- Conditions
- Health Condition 1: null- Patients having Senile Immature Cataract
- Registration Number
- CTRI/2016/03/006708
- Lead Sponsor
- Institute for Post Graduate Teaching Research in Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 113
Inclusion Criteria
1. Men and women 20 in each arm who meet the diagnostic standards of Immature Cataract
2. aged between 35-60 years of age are included in this study.
Exclusion Criteria
Subjects who will be suffering from-
1. Congenital Cataract
2. Mature and hyper mature Cataract
3. Glaucoma
4. Diabetic Retinopathy
5. Macular degeneration
6. Retinitis pigmentosa
7. Whose RBS and Blood Pressure will be not within normal limits
8. Who will be under steroid treatment & or any kind of Immunosuppressive therapy or
9. Under any Cataract inducing medication
will be excluded from this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To evaluate various Ayurvedic treatment for cataract in practice at P.G. centres institutions of India. <br/ ><br>2.To assess the efficacy of test drugs Elaneer Kuzhambu Anjana and Triphaladi compound capsule and chakshushya regimen alone in the management of senile immature cataract. <br/ ><br>3.To evaluate In Vitro Anti- AGE (Advanced Glycation End product) activity of these test drugs. <br/ ><br>Timepoint: Till May-2017
- Secondary Outcome Measures
Name Time Method 4.To evaluate the response of trial drugs on participants having different Prakruti and different types of morphological forms of cataract.Timepoint: Till May-2017